# Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

> **NCT02260830** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 28 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Lu AF11167

## Key facts

- **NCT ID:** NCT02260830
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-03
- **Final completion:** —
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02260830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02260830, "Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02260830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*